- Research article
- Open Access
Allergens of the urushiol family promote mitochondrial dysfunction by inhibiting the electron transport at the level of cytochromes b and chemically modify cytochrome c1
Biological Research volume 54, Article number: 35 (2021)
Urushiols are pro-electrophilic haptens that cause severe contact dermatitis mediated by CD8+ effector T-cells and downregulated by CD4+ T-cells. However, the molecular mechanism by which urushiols stimulate innate immunity in the initial stages of this allergic reaction is poorly understood. Here we explore the sub-cellular mechanisms by which urushiols initiate the allergic response.
Electron microscopy observations of mouse ears exposed to litreol (3-n-pentadecyl-10-enyl-catechol]) showed keratinocytes containing swollen mitochondria with round electron-dense inclusion bodies in the matrix. Biochemical analyses of sub-mitochondrial fractions revealed an inhibitory effect of urushiols on electron flow through the mitochondrial respiratory chain, which requires both the aliphatic and catecholic moieties of these allergens. Moreover, urushiols extracted from poison ivy/oak (mixtures of 3-n-pentadecyl-8,11,13 enyl/3-n-heptadecyl-8,11 enyl catechol) exerted a higher inhibitory effect on mitochondrial respiration than did pentadecyl catechol or litreol, indicating that the higher number of unsaturations in the aliphatic chain, stronger the allergenicity of urushiols. Furthermore, the analysis of radioactive proteins isolated from mitochondria incubated with 3H-litreol, indicated that this urushiol was bound to cytochrome c1. According to the proximity of cytochromes c1 and b, functional evidence indicated the site of electron flow inhibition was within complex III, in between cytochromes bL (cyt b566) and bH (cyt b562).
Our data provide functional and molecular evidence indicating that the interruption of the mitochondrial electron transport chain constitutes an important mechanism by which urushiols initiates the allergic response. Thus, mitochondria may constitute a source of cellular targets for generating neoantigens involved in the T-cell mediated allergy induced by urushiols.
Historically, contact dermatitis has been an example of specific immune reactions to modified self-antigens by a nonimmunogenic small molecule called a hapten . The leaves and branches of trees belonging to the Anacardiaceae family, including nearly 600 species , e.g., poison ivy/oak, Japanese lacquer and the Chilean litre , among others, induce severe delayed hypersensitivity in the human skin exposed to them [4, 5]. Urushiols, the main active compounds in this reaction, constitute a family of electrophilic and lipophilic haptens that, upon oxidation, can modify skin proteins . Notably, after covalent conjugation with self-peptides, haptens are recognized by T cells . Similar to other contact sensitizers, urushiols induce inflammatory reactions mediated by CD8+ T cells , which secrete IFNγ , and are downregulated by CD4+ T cells in mice .
Until recently, it was accepted that electrophilic haptens must first modify skin proteins by attacking free amino or sulfhydryl groups of self-antigens to induce an allergic reaction . Nevertheless, it was recently demonstrated  that unmodified urushiols from poison ivy/oak might be presented on CD1a molecules to human lymphocytes. Thus, current evidence shows two potential nonexclusive mechanisms involved in urushiol-induced allergy: the first one is associated with the presentation of unmodified urushiols as foreign immunogenic antigens, and the second one involves the generation of neoantigens by covalent modification of self-proteins . Furthermore, since mice lack Cd1a because of a massive genetic deletion of group 2 of lipid-presenting molecules, except for Cd1d , they constitute an excellent experimental model for analyzing the role of neoantigens in allergies caused by urushiols.
Although urushiols were described at the beginning of the past century , little is known about the mechanisms by which the electrophilic form is acquired or the nature of their cellular targets. Similarly, the role of urushiols as activators of the innate immune response has been highlighted. Of note, activation of innate immunity plays a pivotal role in allergic responses , as it is necessary for the differentiation of Langerhans cells and their migration from the skin to the draining lymph nodes to trigger a secondary allergic response . In this regard, the results from our previous study  have suggested that urushiols might generate necessary danger signaling and reactive oxygen species (ROS) [14, 15].
In the present study, we used mainly the allergen 3-(10-Z-pentadecenyl)-catechol named litreol , a molecule belonging to the urushiol group of allergens isolated primarily from lacquer japonica and poison oak plants (Additional file 1: Figure S1), which is obtained from Lithraea caustica, commonly known as the litre tree, an endemic plant of the central region of Chile. Litreol induces severe contact dermatitis in susceptible human beings . Since drugs that interfere with the metabolism of fatty acids and through their uptake by mitochondria can modulate the development of allergies, our previous study was designed to show the cross talk between the extent of the allergic response to litreol and mitochondrial function . Moreover, mitochondria have been considered a fundamental platform for activating innate immunity by involving a broad range of innate immune pathways, where they work as signaling platforms to intensify inflammation upon cytotoxic stimuli and contribute to effector responses [17,18,19,20]. Accordingly, we hypothesize here that mitochondria are major sources of cellular targets for generating the neoantigens involved in urushiol-induced allergy.
We used transmission electron microscopy to observ ears of BALB/c mice exposed to litreol to determine the effect at the cellular level. This initial observation revealed that mitochondria underwent dramatic structural and functional alterations. Moreover, diverse biochemical analyses of mitochondrial fractions using specific substrates and inhibitors of electron flow were used to determine the functional targets of different urushiols, including litreol, poison ivy/oak, 3-methyl catheco and 3-pentadecyl phenol. Tritium labeled litreol, 2D gel electrophoresis and mass fingerprinting were used to evaluate the ability of urushiols to chemicaly modify mitochondrial proteins. Our results reveal significan ultrastural and functional alterations of mitochondria, showing that electron transport chain is blocked by urushiols in vitro and in vivo at the level of the complex III.
Litreol induces alterations in the mitochondrial ultrastructure
The observation that litreol induces inflammation in SCID mice, which are devoid of an adaptive immune system, suggests that litreol can stimulate innate immunity . Consequently, we investigated the effect of litreol on skin sections obtained from wild-type mouse ears after 24 h of urushiol painting. The analysis by electron transmission microscopy showed profound ultrastructural changes in keratinocytes, including chromatin decondensation and disorganization of the microfilament system (Fig. 1). The most significant observation was that the mitochondria appeared swollen, containing prominent electron-dense body inclusions in the matrix compared with the mitochondria in the control mice painted with chloroform, the litreol vehicle. To elucidate the mechanisms underlying this mitochondrial damage, we focused our study on the effect of urushiols at the level of the electron transport chain using mitochondria isolated from the rat liver, which is an extremely rich source of respiratory enzyme systems, cytochromes, and other compounds and could be analyzed with the biochemical methods used in the study .
Litreol is a noncompetitive inhibitor of complex III at the level of the cytochrome bc1
Next, to define whether urushiols exerted an inhibitory action along the respiratory chain, we first studied the effect of urushiol on the respiration of rat liver mitochondria in a resting state. As expected, litreol stimulates a resting state of oxygen consumption at the level of complex I due to its redox properties (Fig. 2a). Then, we investigated the effect of litreol on oxygen consumption rates after adding different electron donors in the presence of carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Fig. 2b). The results showed that only N,N,Nʹ,Nʹ-tetramethyl-p-phenylenediamine (TMPD) plus ascorbate an electron donor to complex IV, was able to overcome the inhibition of mitochondrial respiration induced by litreol. Furthermore, we observed similar hyperbolic inhibitory curves when the effects of urushiols and those of known complex III inhibitors were compared, thus suggesting that complex I and II were not involved. Thus, taken together, these results indicate that the inhibition to electron flow induced by urushiols seemed to be restricted at the cytochrome bc1 level.
To define the effect of litreol on the electron flow within complex III, the redox status of both cytochromes b and c was determined by spectrophotometry after the addition of NADH as the substrate in the presence of litreol. As shown in Fig. 3, both b cytochromes were reduced after adding litreol (Fig. 3a), whereas cytochrome c (Fig. 3b) remained oxidized, suggesting that the interruption of electron flow affected one or both b cytochromes.
Complex III is present in the mitochondrial inner membrane and catalyzes electron transport from ubiquinol (QH2) to cytochrome c, coupling the translocation of protons across the membrane . The complex contains ubiquinol (electron donor)-binding site and a cytochrome c (electron acceptor)-binding site. Thus, to understand the mechanisms of litreol inhibition of complex III, we tested whether litreol interferes with the binding of the electron donor duroquinol (Dur) and the electron acceptor cytochrome c. The enzyme kinetics of complex III for Dur and cytochrome c were measured at litreol concentrations of 10 µM. The results (Fig. 3c, d, respectively) from the Hanes-Woolf analysis showed that the inhibition of electron flow through the mitochondrial transport chain was dependent on either the concentration of Dur or cytochrome c, indicating noncompetitive kinetics.
Litreol halts the electron flow between cytochromes bL and bH
To gain deeper insight into the mechanism underlying urushiol-mediated inhibition of mitochondrial respiration, we investigated the effect of litreol on electron flow through both b cytochromes. Accordingly, antimycin A (Ant), as a Qi-specific inhibitor, slowed electron flow. Figure 4 shows the redox status of cytochrome bL (cyt b566) and cytochrome bH (cyt b562) using Dur as the substrate in the presence of 0.1% dodecyl maltoside. The results show that, when litreol was added, cyt b566 was reduced (Fig. 4a), while cyt b562 remained almost totally oxidized (Fig. 4b), indicating that the electron flow was halted only at the level of cyt b566.
Both the catecholic moiety and the aliphatic chain are needed for litreol to inhibit the flow of electrons in complex III
To determine the minimal structural requirements of urushiols to inhibit respiration, we compared the inhibitory effect of poison ivy/oak, pentadecyl catechol, and two non-urushiol analog compounds, pentadecyl phenol and water-soluble 3-methyl catechol, on rat liver-isolated mitochondria. Only at very high concentrations, the two non-urushiol compounds did exert marginal inhibition. Among the urushiols, poison ivy/oak had the most potent effect (Fig. 5), thus suggesting that the increase in double bonds along the aliphatic chain (see urushiols structures at Additional file 1: Figure S1) intensified the allergenicity of urushiols. All the inhibitor molecules, including litreol, were catecholic in nature, and they each have both catechol and aliphatic moieties.
Cytochrome c1 is chemically modified by litreol
Since urushiols might have stopped mitochondrial respiration by directly modifying cytochrome b or altering a different molecule related functionally or structurally to cytochrome b, we next sought to identify the molecular target of litreol. For this purpose, we inhibited the electron chain using 3H-labeled pentadecyl catechol in mitochondria isolated from bovine hearts, and then we analyzed the 3H-labeled proteins by SDS-PAGE stained with Coomassie blue and then by photofluorography (Fig. 6). We observed the preferential radiolabeling of a molecule of approximately 27 kD in the mitoplast and in the inner membrane fractions (Fig. 6). Moreover, the radioactive band overlapped with that of cyt c1 in the Western blots (Fig. 6). Since the mobility of cyt c1 and cyt b is similar on the one-dimensional SDS gels , we sought to analyze more precisely the molecular target of litreol using two-dimensional gel electrophoresis (2D-PAGE) . For this purpose, the radioactive fraction of proteins obtained from the inner membrane of bovine heart mitochondria were enriched by molecular exclusion using a Sephadex G200 column and then separated by 2D-PAGE gels. The photofluorography analysis of proteins separated by 2D-PAGE gels revealed three spots of proteins of 27 KD with different isoelectric points; 6.35, 6.19 and 6.02, respectively (Fig. 7, middle panel). Interestingly, the Coomasie blue staining detected only the spot with isoelectric point 6.35 (Fig. 7, left panel), suggesting that this protein was more abundant than proteins with isoelectric points 6.19 y 6.02. Moreover, the western blot analysis of 2D-PAGE gels revealed that proteins with isoelectric points 6.19 y 6.02 present immunoreactivity with the anti-cytochrome c1 antibody (Fig. 7, right panel). Considering the aminoacidic sequence of the cytochrome c1 (Additional file 1: Figure S2) and the lipophilic nature of litreol, these results suggest that this allergen modifies the lysine residues of cytochrome c1 located inside of or close to the inner membrane (Additional file 1: Figure S2), thus neutralizing the positive charge of the ε-amino groups and thereby shifting the isoelectric point of the protein. The absence of a spot with isolectric point of 6.35 in the immunoblot for cytochrome c1 (Fig. 7, right panel, spot X) suggests that the adduct of litreol-cytochrome c1 that results in a protein with isolectric point of 6.35 loses the immunoreactivity to the antibody used for westernblot analysis due to the distortion of immunodominant epitopes. Alternatively, it could be explained by the fact that some blocking agent used for immunoblots might mask some specific epitopes, thereby preventing antibody binding, such as described for milk. To complement the analyses of identity of the protein modified by litreol, we performed a mass fingerprinting analysis on both radioactive spots in slices excised from the 2D-PAGE SDS slab gel (data not shown). After trypsin in-gel digestion, PAGE was run in parallel with unmodified cyt c1 (control), and four tryptic fragments assignable to cyt c1 were observed at the same spots in both gels (1.246, 1.670, 1.819 and 1.863 kD) (Additional file 1: Figure S3a). However, the radioactive spots from both urushiol-treated samples indicated only two peptides, with sizes of 1.670 and 1.863 kD (Additional file 1: Figure S3b, c). One of the missing fragments likely corresponds to the amino-terminal fragment 1–15 (1.819 kD), SDLELHPPSYPWSHR, on the amino terminus that would be expected to be 2.139 kD after the addition of litreol. The other missing fragment (192–202) of 1.246 kD, WAAEPEHDHRK, is close to the transmembrane region, and after litreol addition, its size would be greater than 2.120 kD. Nevertheless, it was also expected that, after the addition of litreol, proteolytic cleavage at lys 202 would be impaired; therefore, the size of the resulting peptide would likely be greater than 2.279 kD. In both cases, the radioactive fragments are outside the detection limit of the mass spectrometer (Additional file 1: Figure S3). Together, these results strongly suggest that cytochrome c1 is the molecular target of litreol and that the addition of urushiol impairs electron transport through complex III (between cyt bL and cyt bH).
Skin is an essential physical and biological barrier protecting from the penetration of pathogenic microorganisms, and at the same time, it allows gas exchange and respiration and is a substrate for the development of beneficial microbiota . However, the hydrophobic nature of the external layer allows the absorption of natural and manufactured lipidic molecules that are absorbed and can diffuse deep into the epidermis membranes, causing unwanted inflammatory reactions, including contact dermatitis . Between the external coating and the germinal epithelium, a sheet of keratinocytes and Langerhans cells, among other cells, serves as an immune battlefield for lymphocytes coming from capillaries to attack foreign antigens, including lipophilic bacterial constituents from mycobacteria described for the first time by Porcelli et al.  and self-modified proteins by haptens . Of note, urushiols are among the most potent allergens to humans because of their lipophilicity and reactive catechol moiety .
It is well known that mitochondrial functions are intrinsically linked to their morphology . Thus, from the ultrastructural changes observed in the mitochondria following the exposure of keratinocytes to litreol, we show in this study that the inhibition of mouse mitochondrial respiration by urushiols has the same molecular requirements as allergy induction, e.g., contact dermatitis, and the degree of allergenicity is dependent on the catecholic moiety and the number of double bonds present in the pentadecyl side chain (Fig. 5) [30, 31]. Notably, both structural features were required for urushiol-mediated inhibition of electron flow: the long aliphatic chain allows the insertion and trafficking of the allergen within biological membranes, and the catecholic moiety permits the covalent modification of self-proteins and enables the interaction with human CD1a . Thus, our findings, together with our previous observation that urushiols can induce inflammation in SCID mice , suggest that these structures, which are similar to those of ubiquinone, might interfere with some mitochondrial functions, such as the production of the radicalary species that lead to cellular oxidative stress, generating danger signals that can trigger the stimulation of innate immunity [12, 14].
Ubiquinone and urushiols and their quinonic forms are extremely hydrophobic molecules; therefore, they are concentrated in the hydrophobic bilayer of membranes, making them good candidates as competitive inhibitors of electron flow particularly given their similarity with each other. Nonetheless, unexpectedly, the urushiol-mediated inhibition of electron flow was noncompetitive, suggesting that urushiols and ubiquinone do not share the same docking site at cytochrome b (Fig. 3). Moreover, our results show that the electron flow may be blocked because of urushiol mediation between bL and bH, pointing to the discovery of a new docking site-specific to urushiols on cytochrome b. An alternative explanation is that the inhibition may be caused by the distortion of the cytochrome b structure  after the intercalation of the long aliphatic urushiol chain covalently bound to cyt c1 at lys 202, as discussed below.
The inhibition of the electron flow mediated by urushiols at the level of complex III plays an essential role in triggering the initiation of danger signaling [14, 26]. In this regard, it has been shown that antimycin A , a well-known complex III inhibitor, promotes the generation of free radicals  and superoxide, with the consequential stimulation of innate immunity, which subsequently stimulates the adaptive immune response. Furthermore, it has been demonstrated that ROS and superoxide induce the activation of NFκB, a master transcription factor that controls inflammation in innate immune cells . Importantly, by stimulating NFκB, free radicals induce the expression of adhesion molecules on neighboring capillary vessels, which play important roles in lymphocyte homing [36, 37]. Moreover, NFκB induces the local production of a set of pro-inflammatory cytokines, including IL-1, IL-6, and TNF-α . Due to the mitochondrial damage induced by urushiols, it is most likely that the transmembrane potential decreases, leading to the release of cytochrome c and other apoptogenic factors  from mitochondria, thereby inducing apoptosis of keratinocytes  and tumor cells lines .
The intense labeling of the tritiated litreol at cytochrome c1 (Figs. 6 and 7), as identified by tryptic fingerprinting (Additional file 1: Figure S3), was the most intriguing finding because it indicated that urushiols could modify mitochondrial self-proteins that, in turn, can be processed and presented to T lymphocytes.
Altogether, the modification of mitochondrial antigens by urushiols, the induction of ROS and apoptosis [36, 41] generate the perfect scenario for dendritic cell (DCs) maturation, including the expression of CD1a . This process culminates with the migration of DCs to the draining lymph nodes and T cell activation . The presentation of modified self-antigens from apoptotic cells by MHC class II molecules results in CD4+ T cell activation and the downregulation of the adaptive immune response; in contrast the presentation of modified self-antigens on class I molecules to CD8+ T cells promotes further inflammation, as described by Lopez et al. .
In the course of urushiol-induced allergy, mitochondrial antigens can undergo degradation by the mitophagy induced after organelle damage (Fig. 1), resulting in class II presentation to CD4+ T cells . Moreover, mitochondria have a sophisticated and regulated proteolytic system to degrade misassembled or nonfunctional inner membrane proteins [44, 45]. The functional damage to cytochrome bc1 induced by urushiols, by chemical modification, superoxides or free radicals, as a result of the inhibited respiration chain may impair the binding of prohibitins, sensors of the structural integrity of mitochondrial proteins, which is a requisite to undergo partial degradation by AAA proteases located in the mitochondria. In this regard, peptides of more than 10 amino acid residues might be generated from the proteolytic degradation mediated by m-AAA in the matrix, which can be subsequently translocated by the MdL1-like transporter ABCB10  into the intermembrane space . Another pool of peptides can also be generated from proteolytic degradation by i-AAA in the intermembrane space. Once in the intermembrane space, peptides generated by i-AAA, as well as those generated by m-AAA, might subsequently diffuse into the cytosol through pores present in the outer membrane, as reviewed by Arnold and Langer . Since the amino-terminal region of cytochrome c1 faces the intermembrane space, the self-peptides modified by urushiols should diffuse directly to the cytosol and subsequently bind the class I histocompatibility antigens in the endoplasmic reticulum. Under this paradigm, peptides derived from mitochondrial antigens have been described by Fischer-Lindahl et al. , on the cell surface in association with H2-M3 histocompatibility antigen.
Regarding the identification of the molecular targets of urushiols, in this study, we infer the generation of two modified peptides produced by the electrophilic modification of cytochrome c1 (Additional file 1: Figure S3). Since catecholic groups might form covalent adducts with lys or cys, it is tempting to speculate that lys 202 is one of the main targets of urushiols in cytochrome c1, which is in tight proximity with the transmembrane region . The modification of lys 202 by urushiols could inhibit the electron flow at the level of cytochrome b because its long aliphatic chain may alter the structure of cytochrome b at a point critical for halting the transfer of electrons among the b cytochromes. Another possible explanation is that the modification of cytochrome c1 and the inhibition of cytochrome b might be two independent events. For this case, we postulate that urushiols interact noncovalently with cytochrome b, as described for most cytochrome b inhibitors , and similarly to the noncovalent interaction of the poison ivy urushiol with CD1a, as recently described by Kim et al. .
Alignment of the sequences available for cytochrome c1 from data banks (chicken, human, bovine, and mouse) [50,51,52,53] indicates that the hydrophobic transmembrane region and the region towards the amino-terminal sites of cytochrome c1 are conserved among mammals, suggesting that urushiols can similarly modify other mammalian cytochrome c1. However, since urushiols have a very long aliphatic chain, which is approximately 25 Å (Additional file 1: Figure S1), the transport of urushiol-modified peptides into the endoplasmic reticulum through TAP proteins involves an additional problem unless the aliphatic chain is shortened by ω-oxidation, as suggested by Kalergis et al. . Nevertheless, it has been demonstrated that peptides displaying synthetic lateral chains with sizes similar to urushiols might be transported by the TAP system .
The inhibitory effect of urushiols at the level of mitochondrial respiration may represent a critical defense system in plants belonging to the Anacardiaceae family to avoid herbivorous predators and pathogenic fungi [54, 55]. It is noteworthy that Rodentia, being the order with the most mammalian species, including rats and mice, lacks CD1a and almost all group 2 lipid-presenting molecules [9, 10], suggesting an advantageous characteristic for them, perhaps expanding their sources of food.
In addition to gaining new insights into the molecular mechanisms of urushiol-induced dermatitis, this study shows urushiols as new and natural tools that may be evaluated for the development of better adjuvants because of the strong immunogenicity of urushiols and their capacity to induce pro-inflammatory signals via mitochondrial damage . For instance, this urushiol-induced stimulation of the innate immune response might exert a bystander effect, as other non-specific immunostimulants , which could be used as an adjuvant in anti-tumoral immunotherapies to potentiate the specific immune response. In this context, a recent study has evaluated the use of a novel tumor-targeted urushiol-loaded micelle delivery system in a mouse model of breast cancer, showing that these micelles enhanced the accumulation of urushiol in the tumor and thus opening the possibility of their use in the treatment of breast cancer . Concerning to the mechanisms involved in clinical allergy to urushiols in humans, in addition to the direct presentation of unmodified urushiols on CD1a molecules to human lymphocytes , our findings here suggest that there is also the generation of mitochondrial neoantigens, which would stimulate an specific T-cell response independently of CD1a. Finally, our data suggest an unexpected link between a mitochondrial protein and the induction of an allergic reaction. Thus, mitochondria may constitute a source of cellular targets for the generation of neoantigens involved in urushiol-induced allergies.
Collectively, our results revealed that after epicutaneous painting with litreol on mouse ears, mitochondria underwent dramatic structural and functional alterations, showing that oxidative phosphorylation was affected. Furthermore, functional analyses demonstrated that electron flux was halted at the level of cytochromes b, more precisely in between bL (cyt b566) and bH (cyt b562). Subsequent proteomic analysis revealed that cytochrome c1 was the main molecular target of the nucleophilic attack mediated by litreol.
ADP, ascorbate, CCCP, duroquinol, ethylene glycol-bis (β-aminoethyl ether) N,N,Nʹ,Nʹ tetraacetic acid (EGTA), glutamate, 4-(2-hydroxy-ethyl)-l -piperazine-ethanesulfonic acid (HEPES), malate, succinate, N,N,Nʹ,Nʹ-tetramethyl-p-phenylenediamine (TMPD) and 3-methyl catechol were purchased from Sigma Chemical Co. (St. Louis, MO). Pentadecyl phenol was obtained from Cardolite Corporation (Bristol, PA USA). Duroquinol (Dur) was prepared from duroquinone as described previously . Urushiols were dissolved in dimethyl sulfoxide (DMSO; Merck, Darmstadt, Germany). The solvent had no effect on respiration at any of the concentrations employed. All the other reagents were of the highest purity available.
Litreol, 3-(10-Z-pentadecenyl)-catechol, was obtained from the leaves of trees growing in the Olmué area (Chile) and purified by silica gel as described by Gambaro et al. . Poison ivy/oak and pentadecyl catechol were generously provided by Dr. Alfred del Grosso from the FDA (USA). The structural formulas of the urushiols used in this study are shown in Additional file 1: Figure S1. 3H-litreol: (3-pentadecyl-(10,11-3H)-catechol was produced by ChemSyn Science Laboratories (USA) by catalytic reduction of cold litreol under tritium gas flux. The specific activity of the end product was 53.5 mCi/μM, and the tracer was maintained at − 40 °C in ethanol at a concentration of 200 μM until use.
We used BALB/c female mice purchased from Biosonda S.A., (Santiago, Chile). Male Donryu rats of 180–230 g, which were starved for 24 h before the experiments, were from the Animal House Facility Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile. The study was performed in strict accordance with the Guidelines for the Care and Use of Laboratory Animals of the National Commission for Scientific and Technological Research of Chile Universidad de Chile. Bovine hearts were obtained from a 2-year-old female bovine at the Lo Valledor slaughterhouse (Santiago, Chile).
Transmission electron microscopy
The ears of the BALB/c mice were painted with a 1% solution of litreol in chloroform or chloroform alone, as a control as described López et al. . After 24 h, the ears were removed under general anesthesia, and the mice were euthanized. Small pieces of select regions of the ear skin from the control (exposed to solvent) and experimental (treated with litreol) mice were fixed for 6 h at room temperature in a solution containing 3% glutaraldehyde (Polyscience, USA), 100 mM KCl, 2 mM MgCl2, 0.25 M sucrose and 0.1 M PIPES buffer, pH 6.9. Then, these tissues were postfixed in 1% OsO4 in 0.1 M cacodylate buffer, dehydrated, and embedded in Epon (Polyscience) according to the method of Luft . Thin sections were counterstained with uranyl acetate and lead citrate, according to Reynolds . The preparations were examined and photographed at 80 kV on a JEOL 100-B electron microscope at 80 kV (Electronic Microscopy Facility, Pontificia Universidad Católica de Chile).
Rat liver-isolated mitochondria
Mitochondrial suspensions of 50 mg protein/mL were prepared according to Pedersen et al.  with the following modifications: mitochondrial fractions were washed twice at 10,000×g for 10 min and resuspended in a minimal volume of homogenization medium in the absence of bovine serum albumin to avoid adsorption of hydrophobic molecules to serum albumin.
The mitochondrial subfractionation procedure was performed as described by Pavani et al.  and Pedersen et al. . Briefly, the mitochondrial fraction was first treated with digitonin and then centrifuged at 15,000g for 10 min at 5 °C to obtain mitoplasts (pellet). Next, the supernatant was centrifuged at 144,000g for 40 min at 5 °C, and then, the pellet was resuspended in a small volume of buffer, which was composed of the outer membrane fraction (pellet) and its corresponding supernatant, the intermembrane fraction. The mitoplasts were washed twice and sonicated for four 30-s bursts at the maximum energy setting interspersed with 60-s cooling intervals. The resulting suspension was diluted with an equal volume of cold buffer and centrifuged at 15,000g for 10 min at 5 °C. The pellet was discarded, and the supernatant was centrifuged at 144,000g for 50 min at 5 °C. Finally, the pellet was resuspended in a small volume of isolation medium, with the supernatant being the matrix fraction and the pellet being the fraction enriched with the mitochondrial inner membrane (submitochondrial particles).
Cytochrome reduction assays
The reduction in cytochromes b and c was assayed in 100 mM KH2PO4 (pH 7.4) containing 0.5 mg/ml submitochondrial particles and 0.05 mM cytochrome c. The reaction was initiated by adding 0.17 mM NADH and was monitored at 563–577 nm for cytochromes b, and 550–535 nm for cytochrome c  The time of each cycle was 20 s, and the reading was 0.5 s. NADH was added after cycle 9, and 10 µM litreol was added after cycle 18, as indicated by the respective arrows (Fig. 3a, b). In total, 50 cycles were completed. The reduction in cytochromes b566–577 and b562–577 was assayed in 100 mM KH2PO4 (pH 7.4), as previously described [22, 62], containing 0.1% dodecyl maltoside, in the presence of a specific inhibitor of complex III (5 µM antimycin A). The reaction was initiated by adding 20 µM duroquinol, either in the presence or in the absence of 10 µM litreol.
Bovine heart-isolated mitochondria
Mitochondrial suspensions of 50 mg protein/mL were prepared from bovine hearts according to Ragan et al. , washed twice, and resuspended in a minimal volume of homogenization medium (components) in the absence of bovine serum albumin. Fresh mitochondrial preparations were used for the litreol binding experiments, and mitochondrial subfractionation of the outer membrane, inner membrane, and mitoplasts was performed according to Paradies et al. . The protein concentration was determined by a modified Lowry reaction  and standardized with serum albumin.
Assay of oxygen consumption
The rates of oxygen consumption were measured by polarography with a Clark oxygen electrode (Yellow Springs Instrument Co., Yellow Spring, OH, USA) and using a YSI model 53 monitor (Yellow Springs Instrument, Yellow Spring, OH, USA) linked to a 100 mV single-channel recorder . The mitochondrial suspension was equilibrated for 2 min at 25 °C before the urushiols were added. All measurements were taken after a 2 min preincubation period with the allergen. These assays were performed at 25 °C as it is the typical temperature used for these determinations because greater temperatures implicate working with lesser oxygen concentration and higher mitochondrial damage. Moreover, temperatures higher than 25 °C involve stronger outer membrane impairment, lesser ΔΨ, and thereby enhanced H2O2 production.
Incubation of isolated mitochondria with 3H-litreol
Mitochondria were adjusted to a final concentration equivalent to 1 mg/ml of protein. Then, as a tracer, 3H-litreol was added to the preparation and incubated for 30 min at 25 °C. Finally, cold litreol was added to a final concentration of 1 mM and incubated for 10 min to compete with the noncovalent radioactive tracer associated with membrane proteins.
The technique was performed as described by  in a gradient or linear version, with a separating gel from 10 to 20% polyacrylamide and 5% stacking gel. Protein samples were heated for 5 min at 100 °C in the presence of SDS and DTT or 2 β-mercaptoethanol (Merck, Germany). Gels were run at 80 V for 15 h at room temperature. Next, the gels were then fixed and stained with Coomassie Blue.
Samples containing inner membrane from bovine heart mitochondria were heated at 100 °C for 5 min in the presence of 1% SDS in 50 mM Tris–HCl (pH 6.8) and 1 mM EDTA, and then fractionated on a sephadex G-200 column equilibrated with 1% SDS in the buffer described above. The radioactive fraction was concentrated on a Centricon device, and 100 μg of protein was precipitated with 90% acetone and subjected to 2D electrophoresis as described by . Briefly, in the first dimension, samples were separated by isoelectric points using an isoelectric focusing chamber (Bio-Rad, model 155). The pH 4–7 gradient was made in 3,9% acrylamide:bisacrylamide (30:1) gels in the presence of 9.17 M urea, 2% NP-40, 1.6% ampholytes with 4–6 pH range, 0.4% ampholytes with 3–10 pH range. Samples containing 100 μg protein were dissolved in lysis buffer (9.5 M urea, 2% NP-40, 1.6% ampholytes with 4–6 pH range, 0.4% ampholytes with 3–10 pH range, and 5% β-mercaptoethanol) and loaded in the first dimension gels. Isoelectric focusing was performed at 500 V for 18 h followed by 800 V for 1 h. To determine the pH gradient generated in the gels of the first dimension, the control gels were cut in 5 mm length pieces, incubated separately in ultra-pure water for 5 h. Then, the pH was determined in each segment. Afterwards, gels from the first dimension were incubated in 10% glycerol, 5% β-mercaptoethanol, 2.3% SDS and 62.5 mM Tris at pH 6.8 for 2 h. The second dimension was performed in 16% SDS-PAGE at 100 V for 16 h.
Western blot analysis
A monospecific rabbit antiserum to bovine cytochrome c1 and a polyspecific sera to complex III were donated by Diego Gonzalez-Halphen  and used to identify cytochrome c1 and complex III on gels, respectively. The procedure of Towbin et al.  was used. Briefly, mitochondrial preparations or subfractions were run on SDS-PAGE gels as described above and then transferred to a 0.02 nitrocellulose membrane. The membrane was blocked with 2% skim milk in PBS and NaN3 for 2 h at room temperature and then incubated for 15 h at room temperature with antibodies diluted from 1/5,000 to 1/10,000 in blocking buffer. Next, the membranes were washed with PBS-Tween 0.02% and then incubated with a secondary antibody, anti-rabbit IgG conjugated to horseradish peroxidase (HRP, Pierce-Endogen, USA), and assayed with a NBT-BCIP system (Pierce, Endogen). The reaction was stopped with Milli-Q water.
To detect the radioactive proteins on fixed and stained polyacrylamide gels, the procedure previously described by Bonner et al.  was used with minor modification. The gels were soaked in 100% dimethyl sulfoxide (DMSO) twice for 30 min each time and then subjected to a PPO/DMSO procedure. In brief, the gels were impregnated with 2.5-diphenyl oxazole (PPO)-DMSO, rehydrated, dried between dialysis membranes, and exposed to Kodak X-OMAT film at − 70 °C for 24 h for unidimensional gels and 72 h for bidimensional gels. The densitometry analyses of the gels were performed using the Un-Scan-It Gel program (Orem, Utah, USA).
Mass fingerprinting was performed at the Rockefeller University Protein Resource Center HHMI Biopolymer Facility. Slices of the 2D-PAGE containing radioactive spots were digested with trypsin, and the digested protein was subjected to mass analysis. The mass spectrum was compared with the information available in data banks.
The results of the experiments are expressed as the mean ± SEM. Comparisons were made using a one-way analysis of variance (ANOVA) followed by Tukey’s test. All graphics and statistical analyses were performed using Sigma Stat 2.01 (SPSS., Chicago IL, USA). Significance was defined at a p-value ≤ 0.05.
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Carbonyl cyanide m-chlorophenylhydrazone
Reduced nicotinamide adenine dinucleotide
Nuclear factor k-B
Severe combined immunodeficiency
Reactive oxygen species
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
Two-dimensional gel electrophoresis
Martin S, Weltzien HU. T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol. 1994;104(1):10–6. https://0-doi-org.brum.beds.ac.uk/10.1159/000236703.
Vogl O. Oriental lacquer, poison ivy, and drying oils. J Polym Sci. 2000;38(24):4327–35. https://0-doi-org.brum.beds.ac.uk/10.1002/1099-0518(20001215)38:24%3c4327::AID-POLA10%3e3.0.CO;2-3.
Gambaro V, Chamy MC, von Brand E, Garbarino JA. 3-(pentadec-10-enyl)-catechol, a new allergenic compound from Lithraea caustica (Anacardiaceae). Planta Med. 1986;1:20–2. https://0-doi-org.brum.beds.ac.uk/10.1055/s-2007-969056.
Kalish RS, Morimoto C. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells. J Invest Dermatol. 1989;92(1):46–52. https://0-doi-org.brum.beds.ac.uk/10.1111/1523-1747.ep13070998.
Kalish RS, Johnson KL. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J Immunol. 1990;145(11):3706–13.
Byck JS, Dawson CR. Assay of protein-quinone coupling involving compounds structurally related to the active principle of poison ivy. Anal Biochem. 1968;25(1):123–35. https://0-doi-org.brum.beds.ac.uk/10.1016/0003-2697(68)90086-9.
Lopez CB, Kalergis AM, Becker MI, Garbarino JA, De Ioannes AE. CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells. Int Arch Allergy Immunol. 1998;117(3):194–201. https://0-doi-org.brum.beds.ac.uk/10.1159/000024010.
Wakabayashi T, Hu DL, Tagawa Y, Sekikawa K, Iwakura Y, Hanada K, et al. IFN-gamma and TNF-alpha are involved in urushiol-induced contact hypersensitivity in mice. Immunol Cell Biol. 2005;83(1):18–24. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1440-1711.2005.01310.x.
Kim JH, Hu Y, Yongqing T, Kim J, Hughes VA, Le Nours J, et al. CD1a on Langerhans cells controls inflammatory skin disease. Nat Immunol. 2016;17(10):1159–66. https://0-doi-org.brum.beds.ac.uk/10.1038/ni.3523.
Dascher CC, Brenner MB. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol. 2003;24(8):412–8. https://0-doi-org.brum.beds.ac.uk/10.1016/s1471-4906(03)00179-0.
Majima R, Takara J. Uber die synthese des hydro-urushiols. Ber Dtsch Chem Ges. 1915;48:1606–11.
Martin SF. The role of the innate immune system in allergic contact dermatitis. Allergol Select. 2017;1(1):39–43. https://0-doi-org.brum.beds.ac.uk/10.5414/ALX01274E.
Kashem SW, Haniffa M, Kaplan DH. Antigen-presenting cells in the skin. Annu Rev Immunol. 2017;35:469–99. https://0-doi-org.brum.beds.ac.uk/10.1146/annurev-immunol-051116-052215.
Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–5. https://0-doi-org.brum.beds.ac.uk/10.1126/science.1071059.
Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann PS, et al. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol. 2008;180(9):5826–32. https://0-doi-org.brum.beds.ac.uk/10.4049/jimmunol.180.9.5826.
Kalergis AM, Lopez CB, Becker MI, Diaz MI, Sein J, Garbarino JA, et al. Modulation of fatty acid oxidation alters contact hypersensitivity to urushiols: role of aliphatic chain beta-oxidation in processing and activation of urushiols. J Invest Dermatol. 1997;108(1):57–61. https://0-doi-org.brum.beds.ac.uk/10.1111/1523-1747.ep12285632.
Arnoult D, Soares F, Tattoli I, Girardin SE. Mitochondria in innate immunity. EMBO Rep. 2011;12(9):901–10. https://0-doi-org.brum.beds.ac.uk/10.1038/embor.2011.157.
West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol. 2011;11(6):389–402. https://0-doi-org.brum.beds.ac.uk/10.1038/nri2975.
Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015;42(3):406–17. https://0-doi-org.brum.beds.ac.uk/10.1016/j.immuni.2015.02.002.
Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol. 2018;9:1487. https://0-doi-org.brum.beds.ac.uk/10.3389/fphys.2018.01487.
Heisler CR. Mitochondria from rat liver: method for rapid preparation and study. Biochem Educ. 1991;19(1):35–8. https://0-doi-org.brum.beds.ac.uk/10.1016/0307-4412(91)90145-X.
Wang Y, Fang J, Leonard SS, Rao KM. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic Biol Med. 2004;36(11):1434–43. https://0-doi-org.brum.beds.ac.uk/10.1016/j.freeradbiomed.2004.03.010.
van Lis R, Gonzalez-Halphen D, Atteia A. Divergence of the mitochondrial electron transport chains from the green alga Chlamydomonas reinhardtii and its colorless close relative Polytomella sp. Biochem Biophys Acta. 2005;1708(1):23–34. https://0-doi-org.brum.beds.ac.uk/10.1016/j.bbabio.2004.12.010.
O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250(10):4007–21.
Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553(7689):427–36. https://0-doi-org.brum.beds.ac.uk/10.1038/nature25177.
Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D, et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol. 2002;168(6):3079–87. https://0-doi-org.brum.beds.ac.uk/10.4049/jimmunol.168.6.3079.
Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989;341(6241):447–50. https://0-doi-org.brum.beds.ac.uk/10.1038/341447a0.
Martin SF. New concepts in cutaneous allergy. Contact Dermatitis. 2015;72(1):2–10. https://0-doi-org.brum.beds.ac.uk/10.1111/cod.12311.
Vincent AE, Ng YS, White K, Davey T, Mannella C, Falkous G, et al. The spectrum of mitochondrial ultrastructural defects in mitochondrial myopathy. Sci Rep. 2016;6:30610. https://0-doi-org.brum.beds.ac.uk/10.1038/srep30610.
Keil H, Wasserman D, Dawson CR. The relation of chemical structure in catechol compounds and derivatives to poison ivy hypersensitiveness in man as shown by the patch test. J Exp Med. 1944;80(4):275–87. https://0-doi-org.brum.beds.ac.uk/10.1084/jem.80.4.275.
Johnson RA, Haer H, Kirkpatrick CH, Dawson CR, Khurana RG. Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects. J Allergy Clin Immunol. 1972;49(1):27–35. https://0-doi-org.brum.beds.ac.uk/10.1016/0091-6749(72)90120-0.
Xia D, Yu CA, Kim H, Xia JZ, Kachurin AM, Zhang L, et al. Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science. 1997;277(5322):60–6. https://0-doi-org.brum.beds.ac.uk/10.1126/science.277.5322.60.
Drose S, Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem. 2008;283(31):21649–54. https://0-doi-org.brum.beds.ac.uk/10.1074/jbc.M803236200.
Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 2000;466(2–3):323–6. https://0-doi-org.brum.beds.ac.uk/10.1016/s0014-5793(00)01082-6.
Dev A, Iyer S, Razani B, Cheng G. NF-kappaB and innate immunity. Curr Top Microbiol Immunol. 2011;349:115–43. https://0-doi-org.brum.beds.ac.uk/10.1007/82_2010_102.
Lewis RE, Buchsbaum M, Whitaker D, Murphy GF. Intercellular adhesion molecule expression in the evolving human cutaneous delayed hypersensitivity reaction. J Invest Dermatol. 1989;93(5):672–7. https://0-doi-org.brum.beds.ac.uk/10.1111/1523-1747.ep12319838.
Griffiths CE, Nickoloff BJ. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am J Pathol. 1989;135(6):1045–53.
Caamano J, Hunter CA. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev. 2002;15(3):414–29. https://0-doi-org.brum.beds.ac.uk/10.1128/CMR.15.3.414-429.2002.
Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochem Biophys Acta. 1998;1366(1–2):139–49. https://0-doi-org.brum.beds.ac.uk/10.1016/s0005-2728(98)00109-1.
Zepter K, Haffner A, Soohoo LF, De Luca D, Tang HP, Fisher P, et al. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol. 1997;159(12):6203–8.
Russo A, Cardile V, De Ioannes A, Garbarino J. Effect of litreol on the viability of human cancer cells. Chem Biol Interact. 2009;179(2–3):178–84. https://0-doi-org.brum.beds.ac.uk/10.1016/j.cbi.2008.10.013.
Krasteva M, Kehren J, Horand F, Akiba H, Choquet G, Ducluzeau MT, et al. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol. 1998;160(3):1181–90.
Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, Protti MP, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol. 1999;163(1):130–6.
Arnold I, Langer T. Membrane protein degradation by AAA proteases in mitochondria. Biochem Biophys Acta. 2002;1592(1):89–96. https://0-doi-org.brum.beds.ac.uk/10.1016/s0167-4889(02)00267-7.
Gerdes F, Tatsuta T, Langer T. Mitochondrial AAA proteases–towards a molecular understanding of membrane-bound proteolytic machines. Biochem Biophys Acta. 2012;1823(1):49–55. https://0-doi-org.brum.beds.ac.uk/10.1016/j.bbamcr.2011.09.015.
Herget M, Tampe R. Intracellular peptide transporters in human–compartmentalization of the “peptidome.” Pflugers Arch. 2007;453(5):591–600. https://0-doi-org.brum.beds.ac.uk/10.1007/s00424-006-0083-4.
Young L, Leonhard K, Tatsuta T, Trowsdale J, Langer T. Role of the ABC transporter Mdl1 in peptide export from mitochondria. Science. 2001;291(5511):2135–8. https://0-doi-org.brum.beds.ac.uk/10.1126/science.1056957.
Lindahl KF, Byers DE, Dabhi VM, Hovik R, Jones EP, Smith GP, et al. H2–M3, a full-service class Ib histocompatibility antigen. Annu Rev Immunol. 1997;15:851–79. https://0-doi-org.brum.beds.ac.uk/10.1146/annurev.immunol.15.1.851.
Matsuno-Yagi A, Hatefi Y. Ubiquinol:cytochrome c oxidoreductase (complex III). Effect of inhibitors on cytochrome b reduction in submitochondrial particles and the role of ubiquinone in complex III. J Biol Chem. 2001;276(22):19006–11. https://0-doi-org.brum.beds.ac.uk/10.1074/jbc.M101446200.
Suzuki H, Hosokawa Y, Nishikimi M, Ozawa T. Structural organization of the human mitochondrial cytochrome c1 gene. J Biol Chem. 1989;264(3):1368–74.
Gromme M, van der Valk R, Sliedregt K, Vernie L, Liskamp R, Hammerling G, et al. The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. Eur J Immunol. 1997;27(4):898–904. https://0-doi-org.brum.beds.ac.uk/10.1002/eji.1830270415.
Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, et al. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 1998;281(5373):64–71. https://0-doi-org.brum.beds.ac.uk/10.1126/science.281.5373.64.
Zhang Z, Huang L, Shulmeister VM, Chi YI, Kim KK, Hung LW, et al. Electron transfer by domain movement in cytochrome bc1. Nature. 1998;392(6677):677–84. https://0-doi-org.brum.beds.ac.uk/10.1038/33612.
Kim M, Kim C, Kwak S. Antifungal activity of urushiol components in the sap of Korean lacquer tree (Rhus vernicifera stokes). Korean J Plant Resour. 1997;10(3):231–4.
Aristimuno Ficoseco ME, Vattuone MA, Audenaert K, Catalan CA, Sampietro DA. Antifungal and antimycotoxigenic metabolites in Anacardiaceae species from northwest Argentina: isolation, identification and potential for control of Fusarium species. J Appl Microbiol. 2014;116(5):1262–73. https://0-doi-org.brum.beds.ac.uk/10.1111/jam.12436.
Jimenez JM, Salazar ML, Arancibia S, Villar J, Salazar F, Brown GD, et al. TLR4, but neither dectin-1 nor dectin-2, participates in the mollusk hemocyanin-induced proinflammatory effects in antigen-presenting cells from mammals. Front Immunol. 2019;10:1136. https://0-doi-org.brum.beds.ac.uk/10.3389/fimmu.2019.01136.
Zhou H, Qi Z, Xue X, Wang C. Novel pH-sensitive urushiol-loaded polymeric micelles for enhanced anticancer activity. Int J Nanomed. 2020;15:3851–68. https://0-doi-org.brum.beds.ac.uk/10.2147/IJN.S250564.
Boveris A, Oshino R, Erecinska M, Chance B. Reduction of mitochondrial components by durohydroquinone. Biochem Biophys Acta. 1971;245(1):1–16. https://0-doi-org.brum.beds.ac.uk/10.1016/0005-2728(71)90002-8.
Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961;9:409–14. https://0-doi-org.brum.beds.ac.uk/10.1083/jcb.9.2.409.
Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963;17:208–12. https://0-doi-org.brum.beds.ac.uk/10.1083/jcb.17.1.208.
Pedersen PL, Greenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, et al. Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol. 1978;20:411–81. https://0-doi-org.brum.beds.ac.uk/10.1016/s0091-679x(08)62030-0.
Pavani M, Fones E, Oksenberg D, Garcia M, Hernandez C, Cordano G, et al. Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid. Biochem Pharmacol. 1994;48(10):1935–42. https://0-doi-org.brum.beds.ac.uk/10.1016/0006-2952(94)90592-4.
Ragan CI, Wilson MT, Darley-Usmar VM, Lowe PN. Mitochondria: a practical approach. Eynsham: IRL; 1987. p. 340.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.
Plaza C, Pavani M, Faundez M, Maya JD, Morello A, Becker MI, et al. Inhibitory effect of nordihydroguaiaretic acid and its tetra-acetylated derivative on respiration and growth of adenocarcinoma TA3 and its multiresistant variant TA3MTX-R. In Vivo. 2008;22(3):353–61.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–5. https://0-doi-org.brum.beds.ac.uk/10.1038/227680a0.
Vazquez-Acevedo M, Antaramian A, Corona N, Gonzalez-Halphen D. Subunit structures of purified beef mitochondrial cytochrome bc1 complex from liver and heart. J Bioenerg Biomembr. 1993;25(4):401–10. https://0-doi-org.brum.beds.ac.uk/10.1007/BF00762466.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76(9):4350–4. https://0-doi-org.brum.beds.ac.uk/10.1073/pnas.76.9.4350.
Bonner WM, Laskey RA. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974;46(1):83–8. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1432-1033.1974.tb03599.x.
We thank Catherine Eichwald PhD, Fernando Faunes PhD, and Bruno Moltedo PhD for their valuable comments and discussions on the litreol studies. We thank Dr. Diego González-Halphen from Universidad Autónoma de México, Department of Physiology, for the generous gift of polyclonal antibodies to bovine whole complex III and cyt c1. The technical assistance of QBP Miriam Vázquez-Acevedo (UNAM, Mexico) in generating the anti-cytochrome c1 antibody is greatly appreciated. We are indebted to Dr. David del Grosso from NIH for providing the urushiol from poison ivy/oak. We also thank Dr. Joseph Fernández from Rockefeller University, Protein Resource Center HHMI Biopolymer Facility, for expert assistance with the mass fingerprinting analysis of the 2D gels, and Dr. Cecilia Koenig for skilled assistance with electron microscopy interpretation. Finally, we are indebted to the late Dr. Juan Garbarino for his generosity in sharing his knowledge on urushiols with us.
This work was supported by grants from the National Commission for Scientific and Technological Research of Chile (CONICYT) through the National Fund for Scientific and Technological Development (FONDECYT), N° 1180296 (JF), N° 1201600 (MIB) and N° 1210013 (RP), and through the Programa de Apoyo a Centros con Financiamiento Basal FB-210008 (to Fundación Ciencia & Vida).
Ethics approval and consent to participate
All procedures were approved by the Institutional Animal Care (Manual de Bioseguridad, edited by CONICYT in 2008).
Consent for publication
The authors declared that they have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Structure of catecholic and non-catecholic compounds. Figure S2. Analysis of the potential aminoacids targets of litreol in the cytochrome c1. Figure S3. Litreol alters the mass fingerprinting, as indicated by the tryptic fragments from the radioactive spots of the 2D-PAGE gel analyzed by mass spectrometry and compared with the native cytochrome c1.
About this article
Cite this article
Pacheco, R., Quezada, S.A., Kalergis, A.M. et al. Allergens of the urushiol family promote mitochondrial dysfunction by inhibiting the electron transport at the level of cytochromes b and chemically modify cytochrome c1. Biol Res 54, 35 (2021). https://0-doi-org.brum.beds.ac.uk/10.1186/s40659-021-00357-z
- Contact dermatitis
- Electron transport chain
- Mitochondrial respiration
- Cytochrome bc1
- Complex III